Edico Genome and Fabric Genomics have joined forces to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data. This partnership will enable healthcare providers to use Edico Genome’s Dragen Bio-IT platform with Fabric Genomics’ Opal Clinical variant interpretation platform to gain biological insights for both inherited disease and oncology. Edico Genome’s Dragen platform performs ultra-rapid secondary analysis and analyzes a whole human genome at 30X coverage in approximately 20 minutes. It is available in an on-site version and also in the Amazon Web Services cloud. In turn, Fabric Genomics’ Opal Clinical uses machine learning to rapidly identify disease-causing variants through two proprietary algorithms. The two systems have already been successfully implemented together at Rady Children’s Institute for Genomic Medicine, which has used this combined solution for the past year to diagnose patients in the neonatal intensive care unit and pediatric intensive care unit.